HSP90AB1 and cancer: Upon HSP90 dysfunction, these client proteins are inactivated, destabilized, and quickly degrade (the upper path in Figure 2), followed by the failing of the proliferative and defensive potential of tumor cells; consequently, it is expected that HSP90-targeting agents would sometime be used in cancer treatment (reviewed in [51]).